drugset / Trial / NCT05194709
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors
Phase 0
Unknown
40 enrolled
Wuxi People's Hospital
Imbioray (Hangzhou) Biomedicine Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is an interventional, single arm, open-label, investigator-initiated trial (IIT) to evaluate the safety, tolerability, initial efficacy and pharmacokinetics (PK) of anti-5T4 CAR-NK cells in patients with advanced solid tumors.
Timeline
- Start
- 2021-12-30
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-5T4 CAR-NK Cells | Unknown | 4e+09 cells | — |